PureCycle Technologies (PCT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
29 Dec, 2025Executive summary
Achieved significant commercial and operational progress, including first major purchase order from Drake Extrusion and launch of the Run It Back product line with Churchill Container.
Expanded customer trials across multiple segments, with over 29 active trials and more than 20 additional trials in the pipeline, supported by a growing commercial team.
Amended license agreement with Procter & Gamble, securing North American exclusivity and expanding global opportunities.
Achieved operational milestones at Ironton, including nearly 70% onstream time in December and feed rates up to 12,500 lbs/hr.
Positioned for global expansion with vertically integrated strategy, new facility launches, and ongoing investments in growth projects.
Financial highlights
Ended Q4 with just under $16 million in unrestricted cash and $25.8 million in restricted cash; raised $33 million in February 2025 from key investors.
Q4 cash expenses totaled $68 million, including $36 million for growth project equipment; adjusted cash expense was $27 million.
Ongoing monthly cash burn now in the $9–9.5 million range after bringing Denver online.
Holds $118 million in revenue bonds expected to be sold in 2025 to further enhance liquidity.
Major cash uses included $9.3 million for Ironton operations, $41.4 million for growth projects, and $5 million for SOPA Revenue Bond interest.
Outlook and guidance
Confident in ability to sell out Ironton capacity in the near term, driven by strong customer demand and successful trials.
Expecting third-party certification for 7.2 million lbs of inventory by end of Q1, unlocking additional sales.
Augusta project remains on track, with site preparation underway and improved financing prospects due to Ironton’s success.
Final qualification for initial applications with P&G brands expected in Q2 2025, with first production anticipated in Q2 or Q3 2025.
Anticipate improved bond pricing and continued production improvements as operational and commercial performance strengthens.
Latest events from PureCycle Technologies
- Gen 2 technology and regulatory shifts position the company for rapid growth and global expansion.PCT
The 38th Annual Roth Conference23 Mar 2026 - Proposal seeks to lower warrant trigger price and extend expiration, pending majority consent.PCT
Proxy Filing16 Mar 2026 - Record Q4 production and $2.7M revenue growth set the stage for global expansion in 2026.PCT
Q4 202527 Feb 2026 - Scaling advanced PP recycling, PureCycle targets rapid growth and commercial sales in 2025.PCT
Investor presentation3 Feb 2026 - Record production, new sales, and expanded FDA approval offset by ongoing liquidity challenges.PCT
Q2 20242 Feb 2026 - Continuous multi-day operations achieved, expanding into new markets with strong financial footing.PCT
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Record production gains, $90.6M Q3 loss, and new funding set stage for 2025 commercial ramp.PCT
Q3 202415 Jan 2026 - Shelf registration allows resale of major equity stakes as company scales recycling tech globally.PCT
Registration Filing16 Dec 2025 - Resale registration covers over 15M shares, with proceeds from warrants for corporate use.PCT
Registration Filing16 Dec 2025